Skip to content

To study the effect of ayurvedic formulation in the management of Dushta vrana

Randomised controlled clinical study to evaluate the efficacy of kalanusaryadi Taila in the management of Dushta Vrana with special reference to Infected Wound. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071667
Enrollment
60
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr pallavi shrikrishna patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)patients having age between 20 and 60 yrs.2)patients irrespective of gender,socioeconomic class,caste,occupation.3)patients having sign and symptoms of dushta vrana having area of length 6cmxbreadth 6 cmx depth 5cm will be randomly selected

Exclusion criteria

Exclusion criteria: 1) known case of HIV.hepatitis B,uncontrolled diabetes mellitus,2)patients suffering from wound like tubercular ulcers,venous ulcers,leprotic ulcers,malignant ulcers,burns etc.3)wound having excessive loss of tissues wound includes bone,tendon injury,exposed bones.

Design outcomes

Primary

MeasureTime frame
To study the effect kalanusaryadi Taila and Duravadi taila in Dushta vrana.Timepoint: 15days

Secondary

MeasureTime frame
To reduce the Dushta vrana in 15 days . To study the literature related to concept of Dushta vrana. To study the concept of infected wound. To study the concept of kalanusaryadi taila. To study the concept of Durvadi taila Timepoint: 15days with f/u on 0th 3rd 6th 9th 12th & 15th day.

Countries

India

Contacts

Public ContactDr pallavi shrikrishna patil

LRP ayurvedic medical college and hospital PG institute and research centre urun islampurTal walva

shubhasn@gmail.com7709677061

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026